TGF-β synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth
Open accessThe DOI matches its Crossref record; 46 of the 47 references it cites were found in a registry or an index.
Abstract
Malignant mesothelioma (MM) is an incurable malignancy that is caused by exposure to asbestos and is accompanied by severe fibrosis. Because MM is usually diagnosed at an advanced stage and clinical identification of early lesions is difficult, its molecular pathogenesis has not been completely elucidated. Nearly 75% of MM cases have inactivating mutations in the NF2 (neurofibromatosis type 2; Merlin) gene or in downstream signaling molecules of the Hippo signaling cascade, which negatively regulates the transcription factor Yes-associated protein (YAP). In this study, we demonstrate a functional interaction between the Hippo and TGF-β pathways in regulating connective tissue growth factor (CTGF). Expression of CTGF in MM cells was induced by the formation of a YAP-TEAD4-Smad3-p300 complex on the CTGF promoter. Knocking down CTGF expression in MM cells prolonged the survival of xenografted mice, and a significant association was seen between CTGF expression and extracellular matrix deposition in MM xenografts and in patient tissue specimens. We further suggest that CTGF may influence the malignancy of mesothelioma because of the different histological expression patterns observed in human MM tissues. These data suggest that CTGF is an important modulator of MM growth and pathology and represents a novel therapeutic target for this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As previously mentioned in this review, TGF-β itself and its family members have been recognized to be involved in cancer development [81], and TGF-β possesses a pro-oncogenic role in MPM connected to immune suppression [82,83].”
From Chronic Inflammation, Oxidative Stress and Metabolic Plasticity: Three Players Driving the Pro-Tumorigenic Microenvironment in Malignant Mesothelioma (2023) · cites this paper as [83]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Levental, K. R., Yu, H., Kass, L., Lakins, J. N., Egeblad, M., Erler, J. T., Fong, S. F. T., Csiszar, K., Giaccia, A., Weninger, W., et al. (2009) · Cell · doi:10.1016/j.cell.2009.10.027 · Cited by 4,101
Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907 · cited 1×
“Subsequent studies further revealed that TGF- acts as a tumor suppressor in premalignant cells as well as cells progressing through the early stages of carcinogenesis; furthermore, it exerts prooncogenic effects in metastatic tumors (Roberts and Wakefield, 2003; Massagué, 2008).”
BackgroundTEAD mediates YAP-dependent gene induction and growth control
Zhao, B., Ye, X., Yu, J., Li, L., Li, W., Li, S., Yu, J., Lin, J. D., Wang, C.-Y., Chinnaiyan, A. M., et al. (2008) · Genes & Development · doi:10.1101/gad.1664408 · Cited by 2,498 · cited 6×
“In addition to recent studies that indicate that tumor cell–derived CTGF plays an important role in the proliferation of breast cancer cells (Zhao et al., 2008) and growth of pancreatic tumors (Bennewith et al.”
BackgroundMethodInfluentialMassagué, J., Seoane, J., & Wotton, D. (2005) · Genes & Development · doi:10.1101/gad.1350705 · Cited by 2,452
Elucidation of a universal size-control mechanism in Drosophila and mammals
Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370
Growth factors from murine sarcoma virus-transformed cells.
de Larco, J. E., & Todaro, G. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.8.4001 · Cited by 1,461
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098
Advances in Malignant Mesothelioma
Robinson, B. W. S., & Lake, R. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra050152 · Cited by 889
Zhang, N., Bai, H., David, K. K., Dong, J., Zheng, Y., Cai, J., Giovannini, M., Liu, P., Anders, R. A., & Pan, D. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.06.015 · Cited by 804
Hamaratoglu, F., Willecke, M., Kango-Singh, M., Nolo, R., Hyun, E., Tao, C., Jafar-Nejad, H., & Halder, G. (2006) · Nature Cell Biology · doi:10.1038/ncb1339 · Cited by 767
Cited by
Items 201–245 of 245
The Genetic and Proteomic Detereminants of the Risk of Coronary Artery Disease
Almontashiri, N. A. M. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-6541 · Cited by 1
Defining mechanisms directing YAP/TAZ-mediated tumorigenesis
Hiemer, S. E. (2016) · OpenBU (Boston University) · Cited by 1
A dominant role of TGFβ in regulating T-cell size and physiologyPreprint
Eizenberg-Magar, I., Rimer, J., Miller, S., Elyahu, Y., Mark, M., Porat, Z., Reich-Zeliger, S., Monsonego, A., Antebi, Y. E., & Friedman, N. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.06.02.597009 · Cited by 1
Xiong, H., Han, R., Lin, X., Wu, S., & Cao, L. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.08.31.672803 · Cited by 1
ChIP-Sequencingを用いたTGF-βシグナルの解析
大上, 智. (2014) · Institutional Repositories DataBase (IRDB) · doi:10.15083/00009132
The interaction between hedgehog and TGF-β signalling pathways in malignant mesothelioma
Koriya, K. (2013) · ResearchOnline@ND (The University of Notre Dame)
TAZ AS A REGULATOR OF MESENCHYMAL TRANSFORMATION AND CLINICAL AGGRESSIVENESS IN GLIOMAS
Salazar, K. L., Vaillant, B. D., Wani, K., Hollingsworth, F., Diefes, K., Doucette, T. A., Gumin, J., Patel, D. N., Lang, F. F., Rao, G., et al. (2011) · Journal of Investigative Medicine
Castiglioni, I. (2014) · Unitn-eprints PhD (University of Trento) · doi:10.15168/11572_368889
Functional Regulation at the 9p21.3 Genetic Risk Locus in Coronary Artery Disease (CAD)
Antoine, D. (2015) · uO Research (University of Ottawa) · doi:10.20381/ruor-4083
Molecular Mechanisms and Insights into the Nampt Inhibitor (FK866) Resistance in Cancers
Thongon, N. (2017) · Unitn-eprints PhD (University of Trento) · doi:10.15168/11572_369183
The Role of YES-Associated Protein 1 in Ovarian Physiology and Pathology
Lv, X. (2017) · DigitalCommons@UNMC
The role of YAP and TAZ in sprouting angiogenesis
Neto, F. (2018) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT) · doi:10.34626/3wtn-cb18
The control of melanoma by the Hippo pathway
Yang, L. (2018) · Minerva Access (University of Melbourne)
Asbestos Exposure and Lung Carcinogenesis: Mechanism and Applications
Tokgun, P. E., & Tomatir, A. G. (2019) · International Journal of Scientific and Technological Research · doi:10.7176/jstr/5-6-02
Modulation of cancer cell invasion by extracellular vesicles
Tognoli, M. L. (2018) · Oxford University Research Archive (ORA) (University of Oxford) · doi:10.5287/ora-8ga04grdr
Sekido, Y. (2021) · Respiratory disease series · doi:10.1007/978-981-15-9158-7_14
Self-citationZhuang, C., Liu, Y., Yuan, C., Fu, S., Yang, W., Luo, J., & Zhuang, C. (2020) · doi:10.21203/rs.3.rs-64839/v1
Hippo and Sonic Hedgehog signalling pathway modulation of human urothelial tissue homeostasis
Crighton, T. (2020) · White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)
(2013) · Elsevier eBooks · doi:10.1016/b978-0-12-416570-0.00043-3
Pasello, G., Felley‐Bosco, E., & Remon, J. (2022) · Frontiers research topics · doi:10.3389/978-2-88974-818-1
PDGF regulates proliferation of malignant mesothelioma cells via CTGF protein controlPreprint
Fujii, M., Suehiro, T., Hoang, N. T. D., Matsuki, T., Mine, Y., Nikawa, H., & Asano, K. (2022) · Research Square · doi:10.21203/rs.3.rs-1905395/v1
Self-citationSuehiro, T., Ahmad, K. M., Hoang, N. T. D., Xu, B., Komatsu, H., Kurachi, K., Nikawa, H., Mine, Y., Matsuki, T., Asano, K., et al. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae068
Self-citationDuong, L., Jackaman, C., & Nelson, D. J. (2024) · Ageing and Cancer Research & Treatment · doi:10.70401/acrt.2025.0012
Liu, J., Lu, Y., Liu, Y., Zhang, W., Xian, S., Wang, S., Zheng, Z., Lin, R., Jin, M., Zhang, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26691457
Sato, T., Nakanishi, H., Akao, K., Okuda, M., Mukai, S., Kiyono, T., & Sekido, Y. (2021) · Figshare · doi:10.6084/m9.figshare.16829953
Self-citationHoang, N. T. D., Hassan, G., Suehiro, T., Mine, Y., Matsuki, T., & Fujii, M. (2022) · Figshare · doi:10.6084/m9.figshare.21130043
Self-citationHoang, N. T. D., Hassan, G., Suehiro, T., Mine, Y., Matsuki, T., & Fujii, M. (2022) · Figshare · doi:10.6084/m9.figshare.21130045
Self-citationInvestigating the role of the Hippo pathway in epithelial-mesenchymal transition and drug resistance
Bondesson, A. J. (2021) · ResearchWorks at the University of Washington (University of Washington)
Mateus, R. D. (2014) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Kim, Y. M., Lee, S. H., Na, W., Lee, I. J., Kwon, M., Jo, O., & Song, Y. S. (2026) · Medicine · doi:10.1097/md.0000000000047164
悪性中皮腫においてPDGFRの活性化がAKT経路を介してCTGFタンパク質レベルを制御する
M, K. M. A. (2025) · Hiroshima University Institutional Repository
抗がん剤開発を目的としたTEAD阻害薬K-975の腎毒性に関する研究
大槻, 博. (2024) · Institutional Repositories DataBase (IRDB)
Identification et modulation des voies moléculaires impliquées dans l’agressivité du mélanome cutané
Gautron, A. (2019) · theses.fr (ABES) · doi:10.70675/b9c75939z7407z49abzafcbze6e92703d459
The critical role of YAP and TAZ in tubular homeostasis
Ruscica, B. (2024) · theses.fr (ABES) · doi:10.70675/f88d17d8z4673z44c8zb7d3zf1efb9ddfc2f
Jin, R., Zhong, Z., Zhu, R., Zhang, A., Li, J., Yu, F., & Wang, Y. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.113177
YAP/TAZ inhibition refines TGF-β signaling to prevent laryngeal fibrosisPreprint
Nakamura, R., Bing, R., Weber, H., Yoshimatsu, M., Gartling, G. J., Garabedian, M. J., & Branski, R. C. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.05.18.726086
Proliferation of pleural mesothelioma cells is enhanced by the microRNA-197-3p activity
Bononi, I., Mauro, G. D., Tramarin, M. L., Esposito, V., Tonnini, G., Oton, L., Dallan, B., Torreggiani, E., Martini, F., & Tognon, M. G. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1807528
Synthetic lethal screens reveal p300/CBP as a vulnerability for GNAQ-driven uveal melanomas
Zhang, G., Yuan, J., Chen, L., Jin, X.-Y., Zhong-Lu, R., Zhou, Y., Zhou, R., Xiao, Y.-F., Wang, J.-W., Zhang, X., et al. (2026) · Nature Communications · doi:10.1038/s41467-026-77999-8
Inhibition of CCN2/CTGF prevents heterotopic ossification in fibrodysplasia ossificans progressiva
Deber, A., Farfán, N., Ferrer-Roig, M., Moro, J., Rovira, M., Rosa, J. L., & Ventura, F. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.09.040
Wang, M., Li, X.-Z., Zhang, M.-X., Ye, Q.-Y., Chen, Y.-X., & Chang, X. (2021) · doi:10.3389/fonc.2021.738534.s002
Metadata
- Authors
- Fujii, M., Toyoda, T., Nakanishi, H., Yatabe, Y., Sato, A., Matsudaira, Y., Ito, H., Murakami, H., Kondo, Y., Kondo, E., Hida, T., Tsujimura, T., Osada, H., & Sekido, Y.
- Affiliations
- Aichi Cancer Center (JP)
- National Institute of Health Sciences (JP)
- Hyogo Medical University (JP)
- Corresponding author
- Fujii, Makiko
- Sekido, Yoshitaka
- ORCID
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2012-02-13
- Volume
- 209
- Issue
- 3
- Pages
- 479-494
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC3302232
- OpenAlex
- W2100842035
- Cited by
- 224
- References
- 47
- Citations by year
- 2026: 5 · 2025: 7 · 2024: 18 · 2023: 10 · 2022: 19 · 2021: 23 · 2020: 21 · 2019: 19 · 2018: 30 · 2017: 14 · 2016: 16 · 2015: 16 · 2014: 12 · 2013: 9 · 2012: 4
- FWCI
- 6.21
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- Funders
- Takeda Science Foundation (H18-1-3-3-1)
- Ministry of Education, Culture, Sports, Science and Technology (H18-1-3-3-1)
- Kobayashi Foundation for Cancer Research
- Aichi Cancer Research Foundation
- Vlaamse regering
- Japan Society for the Promotion of Science (23592788, H18-1-3-3-1, 22590375, 22700935, 22300338, 21590457, 20590420, 23590438)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Occupational and environmental lung diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- malignant mesothelioma, TGF-beta signaling, Hippo signaling pathway, connective tissue growth factor, YAP, neurofibromatosis type 2, Merlin, Smad3, TEAD4, P300, extracellular matrix deposition, tumor growth, asbestos, therapeutic target
- MeSH terms
- Animals, Base Sequence, DNA, Neoplasm, Extracellular Matrix, Female, Humans, Mesothelioma, Mice, Nude, Molecular Sequence Data, Nuclear Proteins, Promoter Regions, Genetic, Transcription Factors, Signal Transduction, Transcriptional Activation, Gene Expression, Transforming Growth Factor beta, Genes, Neurofibromatosis 2, Cell Cycle Proteins, Cell Line, Tumor, Cell Proliferation, Mice, Smad Proteins, Connective Tissue Growth Factor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.